WUXI XDC (02268) Company Profile - Company Info, Industry & Management

返回 Overview News Financials Shareholders Profile IPO ›

Industry

CRO/CDMO 0.25%

14 stocks in this industry

0 >7%

0 5~7%

2 3~5%

6 0~3%

0 0%

3 0~3%

2 3~5%

0 5~7%

1 >7%

Down 8 Up 6

Industry RankingsValue (HKD)Rank

Revenue (Last FY)6.97B8/14

Net Profit (Last FY)1.74B4/14

ROE (Last FY)13.80%2/14

Change is the 2026-10-09 close against the previous close; the industry change is the equal-weighted average of its stocks. Sub-industry classification is maintained by cibo. Last FY is each company's latest annual report. Net profit is profit attributable to owners of the parent; ROE = net profit / closing equity attributable to owners. Non-HKD statements are converted at ECB reference rates.

Management

NamePosition

药明合联生物技术有限公司 Executive Director

李锦才 Executive Director

张靖伟 Executive Director

席晓捷 Executive Director

陈智胜 Non-Executive Director

施明 Non-Executive Director

顾继杰 Non-Executive Director

Ulf Grawunder Independent Non-Executive Director

Kenneth Walton Hitchner III Independent Non-Executive Director

Hao Zhou Independent Non-Executive Director

Board list from the HKEXnews "List of Directors and their Role and Function", as of 2025-06-27.

About this page

This page shows WUXI XDC (02268) company information, related securities, the price change distribution and in-industry rankings within its sub-industry, and the board of directors. Quotes come from HKEX Daily Quotations, financial metrics from each company's latest annual report, and the director list from HKEXnews.

WUXI XDC 02268

Company Information

Industry

Management

WUXI XDC 02268·

Company Information

Industry

Management

WUXI XDC 02268